Clinical Trials Sponsored by National Institute of Cancerología

Total 26683 results

National Cancer Institute (NCI)

Withdrawn

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid Cancer

Metastatic Thyroid Cancer
National Cancer Institute (NCI)

Withdrawn

Feasibility of Identifying a Chinese Study Population and Eligible Pediatric Cancer Cases, and Linking the Two Groups to Assess the Role of Periconceptional Folic Acid Supplements in Risk of Pediatric Cancer.

Pediatric Leukemia | Pediatric Brain Neoplasms | Other Pediatric Cancers
National Cancer Institute (NCI)

Withdrawn

MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma

Multiple Myeloma
National Eye Institute (NEI)

Completed

Evaluation and Treatment of People With Eye Diseases

Eye Diseases

United States
National Cancer Institute (NCI)

Completed

Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development

Cancer

United States
National Cancer Institute (NCI)

Terminated

Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer

Melanoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Gastrointestinal Cancer

United States
National Cancer Institute (NCI)

Terminated

Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum

Carcinoma, Non-Small-Cell Lung | Esophageal Neoplasms | Mesothelioma | Carcinoma, Small Cell

United States
National Cancer Institute (NCI)

Completed

Follow-up of Breast Cancer and Multiple Myeloma Patients Previously Enrolled in NIH Gene Therapy Studies

Gene Transfer

United States
National Eye Institute (NEI)

Completed

Natural History and Genetic Studies of Usher Syndrome

Retinitis Pigmentosa | Usher Syndrome | Retinitis Pigmentosa Syndromic | Congenital Deafness | Retinitis Pigmentosa and Deafness

United States
National Cancer Institute (NCI)

Completed

AZD8055 for Adults With Recurrent Gliomas

Glioblastoma Multiforme | Malignant Glioma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma | Brainstem Glioma

United States
National Eye Institute (NEI)

Completed

Clinical and Genetic Studies in Families With Myopia and Related Diseases

Myopia

United States, China
National Cancer Institute (NCI)

Completed

An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ...

Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer

United States
National Cancer Institute (NCI)

Terminated

Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma

Skin Cancer | Metastatic Melanoma

United States
National Eye Institute (NEI)

Terminated

Tissue Studies of Human Eye Diseases

Age-Related Macular Degeneration | Uveitis | Diabetic Retinopathy | Retinal Disease | Corneal Disease

United States
National Eye Institute (NEI)

Completed

Clinical and Molecular Studies in Families With Glaucoma and Related Diseases

Glaucoma

United States, China
National Eye Institute (NEI)

Withdrawn

Ustekinumab for Active Sight-Threatening Uveitis

Uveitis
National Cancer Institute (NCI)

Terminated

Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas

Esophageal Cancer | Thymoma | Lung Cancer | Thoracic Sarcomas | Mesolthelioma

United States
National Cancer Institute (NCI)

Terminated

A Pilot Study of Inpatient Hospice With Procurement of Brain Tumor Tissue on Expiration for Research Purposes

PNET | Gliomas | Pineal Tumors | Ependymomas | PCNSL (Primary CNS Lymphoma)

United States
National Cancer Institute (NCI)

Completed

A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas

Rhabdomyosarcoma | Ewing's Sarcoma

United States
National Cancer Institute (NCI)

Terminated

Vemurafenib and White Blood Cell Therapy for Advanced Melanoma

Melanoma | Metastatic Cancer

United States
National Cancer Institute (NCI)

Completed

Ketoconazole Plus Docetaxel to Treat Prostate Cancer

Prostatic Neoplasms

United States
National Cancer Institute (NCI)

Terminated

Ixabepilone to Treat Cervical Cancer

Cervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Carcinoma | Cervical Carcinoma, Non-SquamousType

United States
National Cancer Institute (NCI)

Completed

Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer

Non-Small-Cell Lung Carcinoma

United States, Mexico, Bolivia, Peru, Venezuela
National Cancer Institute (NCI)

Completed

AZD2171 to Treat Children and Adolescents With Solid Tumors or Acute Myelogenous Leukemia

Acute Myelogenous Leukemia | Refractory or Recurrent Solid Tumors

United States
National Cancer Institute (NCI)

Completed

Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors

Neuroendocrine Tumors | Von Hippel-Lindau Syndrome | Hippel-Lindau Disease

United States
National Cancer Institute (NCI)

Terminated

A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma

Multiple Myeloma | Smoldering Multiple Myeloma | Myeloma

United States
National Cancer Institute (NCI)

Terminated

Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer

Metastatic Cancer | Metastatic Melanoma | Metastatic Renal Cell Cancer

United States
National Cancer Institute (NCI)

Withdrawn

GRN1005 for Brain Metastases From Breast or Lung Cancer

Breast Cancer | Breast Neoplasms | Lung Neoplasms | Lung Cancer
National Cancer Institute (NCI)

Terminated

Lapatinib in Stage IV Melanoma With ERBB4 Mutations

Malignant Melanoma

United States
National Cancer Institute (NCI)

Completed

Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial

Histologically or Cytologically Confirmed Pancreatic Ca | Unresectable or Borderline Resectable Pancreatic Ca

United States
National Cancer Institute (NCI)

Completed

Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer

Prostatic Neoplasms

United States
National Cancer Institute (NCI)

Terminated

Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols

Gliosarcoma | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma | Oligodendroglioma | Glioblatoma

United States
National Eye Institute (NEI)

Terminated

Immunogenetic Mechanisms in Behcet's Disease

Uveitis | Behcet's Disease

United States
National Cancer Institute (NCI)

Terminated

CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer

Cervical Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Mesothelioma

United States
National Cancer Institute (NCI)

Completed

Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma

Myeloma-Multiple | Myeloma, Plasma-Cell

United States
National Cancer Institute (NCI)

Completed

Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies

Non-Small-Cell Lung Carcinoma | Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura | Advanced Esophageal Cancers | Primary Small Cell Lung Cancers | Pleural Mesotheliomas

United States
National Cancer Institute (NCI)

Completed

Acceptance and Commitment Therapy for Adolescents and Young Adults With Neurofibromatosis and Chronic Pain

Neurofibromatosis

United States
National Cancer Institute (NCI)

Completed

DoD-NCI TRICARE Feasibility Study

Cancer

United States
National Cancer Institute (NCI)

Completed

Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers

Kidney Cancer | Prostate Cancer | Bladder Cancer

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediatric Patients With Solid Tumors and Leukemias

Lymphoma | Leukemia

United States
National Cancer Institute (NCI)

Completed

CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII

Glioblastoma | Brain Cancer | Malignant Glioma | Gliosarcoma

United States
National Eye Institute (NEI)

Completed

Blood and Saliva Sample Collection for AREDS 2

Eye Diseases | Age-Related Macular Degeneration

United States
National Cancer Institute (NCI)

Completed

Pomalidomide for Chronic Graft-versus-Host Disease

Graft vs Host Disease | Graft-Versus-Host Disease

United States
National Cancer Institute (NCI)

Completed

A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain Tumors

Brain Cancer | Brain Neoplasm | Brain Tumor, Primary

United States
National Cancer Institute (NCI)

Completed

18F-DCFBC PET/CT in Prostate Cancer

Prostatic Neoplasms | Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer

Adenocarcinoma | Breast Cancer | Colorectal Cancer | Ovarian Cancer

United States
National Cancer Institute (NCI)

Terminated

Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TRAIL Bound to the DR4 Receptor

Kidney Cancer | Renal Cancer

United States
National Cancer Institute (NCI)

Withdrawn

Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST)

Neoplasms, Nerve Tissue | Peripheral Nervous System Diseases | Heredodegenerative Disorders, Nervous System | Neurofibromatosis 1
National Eye Institute (NEI)

Completed

Generation of Induced Pluripotent Stem (iPS) Cell Lines From Skin Fibroblast Cells of Participants With Age-Related Macular Degeneration

AMD

United States
National Cancer Institute (NCI)

Completed

Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction

Neoplasms | Lymphomas

United States

Clinical Trials Sponsored by National Institute of Cancerología

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations